The use of dual antiplatelet therapy in high-risk patients with acute coronary syndromes
Guthrie, R.M.
Journal of Family Practice 64(12 Suppl)
2015
ISSN/ISBN: 1533-7294 PMID: 26845006 Document Number: 683398
Document emailed within 1 workday
Related Documents
Fake, A.; Ranchord, A.; Harding, S.; Larsen, P. 2017: Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review Current Cardiology Reviews 13(4): 325-333Mehta, S.R. 2002: Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines Journal of Invasive Cardiology 14 Suppl E: 27e-34e; Quiz 35e
Clem, J.R.; Falls, S. 1998: Advances in antiplatelet therapy for acute coronary syndromes South Dakota Journal of Medicine 51(7): 233-234
Guha, S.; Sardar, P.; Guha, P.; Roy, S.; Mookerjee, S.; Chakrabarti, P.; Deb, P.K.; Chaudhuri, U.; Deb, S.; Karmakar, R.; Dasgupta, A.K.; Lahiri, P. 2009: Dual antiplatelet drug resistance in patients with acute coronary syndrome Indian Heart Journal 61(1): 68-73
Muslimova, E.F.; Afanasiev, S.A.; Rebrova, T.Yu.; Sergienko, T.N.; Repin, A.N. 2017: Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy Terapevticheskii Arkhiv 89(5): 74-78
Wilczynski, M.; Wybraniec, M.T.; Milewski, K.; Sanak, M.; Wita, K.; Buldak, L.; Kondys, M.; Buszman, P.; Bochenek, A. 2014: Eptifibatide infusion versus placebo in high risk patients with non-st segment elevation acute coronary syndromes managed with urgent coronary artery bypass graft surgery. a prospective multicenter randomized placebo-controlled clinical trial Journal of Cardiovascular Surgery 2014
Degrauwe, S.; Iglesias, J.F. 2016: Dual antiplatelet therapy for treatment and secondary prevention of coronary artery disease: indications, modalities and duration Revue Medicale Suisse 12(520): 1022-6 1028-34
Lala, A.; Berger, J.S. 2011: Percutaneous coronary intervention for acute coronary syndromes: no difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding Evidence-Based Medicine 16(3): 80-81
Kerr, A.J.; Lin, A.; Lee, M.; Ternouth, I.; Killion, B.; Devlin, G. 2013: Risk stratification and timing of coronary angiography in acute coronary syndromes: are we targeting the right patients in a timely manner? (ANZACS-Qi 1) New Zealand Medical Journal 126(1387): 69-80
Xu, J.J.; Tang, X.F.; Song, Y.; Xu, N.; Yao, Y.; Wu, Y.; Zhang, J.; Gao, Z.; Chen, J.; Gao, R.L.; Yang, Y.J.; Yuan, J.Q. 2017: Impact of CYP2C19 genotypes on antiplatelet therapy among Chinese patients with acute myocardial infarction after percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 45(2): 116-120
Komiya, R.; Kamintani, K.; Kubo, E.; Hattori, M.; Kataoka, H.; Iwase, Y.; Miyoshi, H.; Minami, M.; Kato, S.; Arai, R.; Yoshida, H. 2014: Perioperative management and postoperative complication rates of patients on dual antiplatelet therapies after coronary drug eluting stent implantation Masui. Japanese Journal of Anesthesiology 63(6): 629-635
Costache, I.l.; Rusu, C.; Ivanov, I.; Popescu, R.; Petriş, A. 2012: Clopidogrel resistance--risk factor in patients with acute coronary syndromes Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 383-388
Timóteo, A.T.; Fiarresga, A.ón.; Feliciano, J.; Pelicano, N.; Ferreira, L.; Oliveira, J.é A.; Serra, J.é; Ferreira, R.; Quininha, J. 2006: Impact of combination medical therapy on mortality in patients with acute coronary syndromes Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 25(12): 1109-1118
Trenk, D. 2009: Proton pump inhibitors for prevention of bleeding episodes in cardiac patients with dual antiplatelet therapy - between Scylla and Charybdis? International Journal of Clinical Pharmacology and Therapeutics 47(1): 1-10
Oomman, A.; Ramachandran, P.; Shanmugapriya; Subramanian, P.; Nagaraj, B.M.S. 2003: A novel trigger for acute coronary syndromes: the effect of lunar cycles on the incidence and in-hospital prognosis of acute coronary syndromes--a 3-year retrospective study Journal of the Indian Medical Association 101(4): 227-228
Hashimoto, T.; Kambara, H.; Fudo, T.; Uozu, K.; Tokunaga, S.; Tamaki, S.; Kawai, C. 1988: Dual energy emission computed tomography with 99mTc pyrophosphate and 201T1 in evaluating coronary reperfusion therapy in patients with acute myocardial infarction Journal of Cardiology 18(2): 291-297
Hinneburg, I. 2011: Ticagrelor: a novel antiplatelet agent for patients with acute coronary syndrome Medizinische Monatsschrift für Pharmazeuten 34(7): 226-232
Curry, W.J.; Chambers, C.E.; Curry, G.W.; Curry, E.W. 2018: The art of delivering evidence-based dual antiplatelet therapy Journal of Family Practice 67(12): 758-766
Johnston, N.; Bergdahl, E.; Samnegard, A.; Kenttä, L.; Holm, A.; Petursson, P.; Bäck, M. 2018: ST-elevation myocardial infarction and dual antiplatelet therapy: new guidelines Lakartidningen 115
Bozzani, A.; Ferlini, M.; Rossini, R.; Musumeci, G.; Arici, V.; Bramucci, E.; Setacci, C. 2015: Antiplatelet therapy management in patients with coronary stent undergoing vascular surgery Journal of Cardiovascular Surgery 56(4): 681-683